| 000 | 00985 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514002209.0 | ||
| 264 | 0 | _c20020228 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1469-493X | ||
| 024 | 7 |
_a10.1002/14651858.CD002202 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, S | |
| 245 | 0 | 0 |
_aHydroxyurea for sickle cell disease. _h[electronic resource] |
| 260 |
_bThe Cochrane database of systematic reviews _c2001 |
||
| 300 |
_aCD002202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAntisickling Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHemoglobin SC Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aOlujohungbe, A | |
| 773 | 0 |
_tThe Cochrane database of systematic reviews _gno. 2 _gp. CD002202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/14651858.CD002202 _zAvailable from publisher's website |
| 999 |
_c11336340 _d11336340 |
||